GlaxoSmithKline Plc (GSK)

41.22
0.36 0.88
NYSE : Health Technology
Prev Close 40.86
Open 41.15
Day Low/High 40.95 / 41.28
52 Wk Low/High 31.43 / 48.25
Volume 2.71M
Avg Volume 3.33M
Exchange NYSE
Shares Outstanding 2.51B
Market Cap 103.17B
EPS 2.40
P/E Ratio 23.48
Div & Yield 1.97 (4.81%)
GlaxoSmithKline Gets a Boost

GlaxoSmithKline Gets a Boost

Drugmaker's charts show positive signs ahead.

Gilead's Earnings Fail to Impress

Gilead's Earnings Fail to Impress

The company is losing sales aggressively as it fails to create any business substantial enough to make up for the shrinking sales in its Hepatitis C drugs.

Innoviva Is Attractive Play in Biotech

Innoviva Is Attractive Play in Biotech

Strong balance sheet and royalties are big positives for Innoviva.

Novartis to Exit its Consumer Business and 4 Other Stories You Must Know Tuesday

Novartis to Exit its Consumer Business and 4 Other Stories You Must Know Tuesday

With Wall Street responding to one of the strongest rallies in years, here's what you need to know premarket Tuesday.

GlaxoSmithKline Looks Poised for an Upside Move

GlaxoSmithKline Looks Poised for an Upside Move

GSK is still below the declining 200-day moving average line but a rally of $2 will challenge the line.

10 Favorite Healthcare Stocks for 2018: Medical Marijuana to Opioid Treatment

10 Favorite Healthcare Stocks for 2018: Medical Marijuana to Opioid Treatment

We see a notable shift away from traditional large-cap pharmaceutical stocks to more specialized niches.

5 Products You Didn't Know Were Made By Pfizer

5 Products You Didn't Know Were Made By Pfizer

Pfizer is reportedly planning to sell its consumer healthcare business in an auction next month

European Stocks Euphoria Is Running High ... Maybe Too High

European Stocks Euphoria Is Running High ... Maybe Too High

European stock markets are priced almost to perfection ahead of an earnings deluge.

Nascar Champ Danica Patrick--'I'm Not That Into Cars'

Nascar Champ Danica Patrick--'I'm Not That Into Cars'

You would think that Nascar champion Danica Patrick would be a gear head who can talk makes, models and car parts and and car collector with garages brimming with rare autos. You would be wrong.

Another Day - Another Busy Slate of Earnings

Another Day - Another Busy Slate of Earnings

Ford Motor Co. leads a list of notable earnings reports being released throughout the day on Wednesday

China Was Right to Walk Away From Failed U.S. Trade Talks

China Was Right to Walk Away From Failed U.S. Trade Talks

The collapse of the Sino-American session on tariffs and access translates into market action for investors, and inaction on improved trade.

These Stocks Are Showing Red Flags -- Here's When to Sell

These Stocks Are Showing Red Flags -- Here's When to Sell

You don't want to own these four 'toxic stocks'.

GlaxoSmithKline Continues to Strengthen

GlaxoSmithKline Continues to Strengthen

Technical indicators suggest GSK can see further significant gains in 2017.

More Companies Pull Advertising to Protest Google's Treatment of Extremist Content

More Companies Pull Advertising to Protest Google's Treatment of Extremist Content

Britain is the second largest market for Google, generating $7.8 billion primarily from advertising in 2016.

Still Bullish on GlaxoSmithKline

Still Bullish on GlaxoSmithKline

After another technical look at GSK, this FTSE component is still going strong.

Cramer: Money's Being Thrown at Almost Everything in the Market

Cramer: Money's Being Thrown at Almost Everything in the Market

There are nearly too many surging sectors to count.

Why I'm Optimistic About GlaxoSmithKline

Why I'm Optimistic About GlaxoSmithKline

Check out GSK's well developed base pattern.

Gilead Has 'Good News' But is it Enough?

Gilead Has 'Good News' But is it Enough?

Gilead Sciences' bictegravir suppressed HIV better than rival Glaxo's dolutegravir.

3 Stocks Poised for Gains Under the Donald Trump Era

3 Stocks Poised for Gains Under the Donald Trump Era

With stocks at record highs, there are still buying opportunities, but investors should be selective.

Now That Dow Has Hit 20,000, GM and Nike Are Hot Stocks

Now That Dow Has Hit 20,000, GM and Nike Are Hot Stocks

Some of Wall Street's biggest stocks are teetering on the edge of breakout territory this week. Here are five of them.

Bullish and Bearish Reversals in the Market

Bullish and Bearish Reversals in the Market

These companies show signs of a change of direction.

Tracing Benjamin Graham's Descendants

Tracing Benjamin Graham's Descendants

Firms' 13F filings show how they've followed in the footsteps of the father of value investing.

Donald Trump Election Victory Boosts Some Stocks and Sectors

Donald Trump Election Victory Boosts Some Stocks and Sectors

As we all know, the stock market and the economy abhor uncertainty.

Cramer: Don't Just Stand There Like Bambi; Sell Some

Cramer: Don't Just Stand There Like Bambi; Sell Some

Stocks in the health care sector seem to have no underpinnings whatsoever.

Cramer: Credibility Is a Precious Market Commodity

Cramer: Credibility Is a Precious Market Commodity

And if it's lost, good luck getting it back.

What to Watch This Week: Apple Earnings, Third Quarter GDP

What to Watch This Week: Apple Earnings, Third Quarter GDP

For the week of October 24, investors await quarterly results from a slew of major companies, including Apple, along with the first estimate of third quarter GDP.

9 Stocks for the Bank of England's Corporate-Bond Purchases

9 Stocks for the Bank of England's Corporate-Bond Purchases

Which stocks will be most favored by the corporate-bond purchases?

4 Stocks to Buy in This Vulnerable Market

4 Stocks to Buy in This Vulnerable Market

This market is like a leaky helium balloon; watch out for sudden downdrafts.

Portfolio Roundup: Humira Helps Buoy AbbVie Shares

Portfolio Roundup: Humira Helps Buoy AbbVie Shares

The drug maker continued to rally Monday.